medigraphic.com
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

2012, Number 1

<< Back

Rev Invest Clin 2012; 64 (1)

Alteraciones visuales asociadas al tabaquismo. Una revisión sistemática a propósito de un caso clínico

Sansores RH, Ramírez-Venegas A, Pérez-Bautista Ó, Bustos M

Language: Spanish
References: 77
Page: 89-101
PDF size: 200.84 Kb.


Text Extraction

No abstract


REFERENCES

  1. Ezzati M, López AD. Estimates of global mortality attributable to smoking in 2000.Lancet 2003; 362: 847-52.

  2. Jager RD, Mieler WF, Miller JW. Age-related macular degeneration. N Engl J Med 2008; 358: 2606-17.

  3. Stan MN, Bahn RS. Risk factors for development or deterioration of Grave´s ophthalmopathy. Thyroid 2010; 20: 777-83.

  4. Thornton J, Edwards R, Mitchell P, Harrison RA, Buchan I, Kelly SP. Smoking and age-related macular degeneration: a review of association. Eye 2005; 19: 935-44.

  5. Neuner B, Komm A, Wellmann J, Dietzel M, Pauleikhoff D, Walter J, et al. Smoking history and the incidence of age-related macular degeneration-results from the Muenster Aging and Retina Study (MARS) cohort and systematic review and metaanalysis of observational longitudinal studies. Addict Behav 2009; 34: 938-47.

  6. Despriet DD, Van Duijn CM, Oostra BA, Uitterlinden AG, Hofman A, Wright AF, et al. Complement component C3 and risk of age-related macular degeneration. Ophthalmology 2009; 116: 474-80.

  7. Cong R, Zhou B, Sun Q, Gu H, Tang N, Wang B. Smoking and the risk of age-related macular degeneration: a metaanalysis. Ann Epidemiol 2008; 18: 647-56.

  8. Bauer P, Barthelmes D, Kurz M, Fleischhauer JC, Sutter FK. The potential effect of population development, smoking and antioxidant supplementation on the future epidemiology of age-related macular degeneration in Switzerland. Klin Monbl Augenheilkd 2008; 225: 376-9.

  9. Chong EW, Kreis AJ, Wong TY, Simpson JA, Guymer RH. Alcohol consumption and the risk of age-related macular degeneration: a systematic review and meta-analysis. Am J Ophthalmol 2008; 145: 707-15.

  10. Conley YP, Jakobsdottir J, Mah T, Weeks DE, Klein R, Kuller L, Ferrell RE, Gorin MB. CFH, ELOVL4, PLEKHA1 and LOC387715 genes and susceptibility to age-related maculopathy: AREDS and CHS cohorts and meta-analyses. Hum Mol Genet 2006; 15: 3206-18.

  11. Bojanowski CM, Shen D, Chew EY, Ning B, Csaky KG, Green WR, et al. Anapolipoprotein E variant may protect against agerelated macular degeneration through cytokine regulation. Environ Mol Mutagen 2006; 47: 594-602.

  12. Smith W, Assink J, Klein R, Mitchell P, Klaver CC, Klein BE, et al. Risk factors for age-related macular degeneration: Pooled findings from three continents. Ophthalmology 2001; 108: 697-704.

  13. Klein R, Klein BE, Knudtson MD, Meuer SM, Swift M, Gangnon RE. Fifteen-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye Study. Ophthalmology 2007; 114: 253-62.

  14. Van Newkirk MR, Nanjan MB, Wang JJ, Mitchell P, Taylor HR, McCarty CA. The prevalence of age-related maculopathy: the visual impairment project. Ophthalmology 2000; 107: 1593-600.

  15. Meyers SM. A twin study on age-related macular degeneration. Trans Am Ophthalmol Soc 1994; 92: 775-843.

  16. Meyers SM, Greene T, Gutman FA. A twin study of age-related macular degeneration. Am J Ophthalmol 1995; 120: 757-66.

  17. Seddon JM, Cote J, Page WF, Aggen SH, Neale MC. The US twin study of age-related macular degeneration: relative roles of genetic and environmental influences. Arch Ophthalmol 2005; 123: 321-7.

  18. Bressler SB, Muñoz B, Solomon SD, West SK; Salisbury Eye Evaluation (SEE) Study Team. Racial differences in the prevalence of age-related macular degeneration: the Salisbury Eye Evaluation (SEE) Project. Arch Ophthalmol 2008; 126: 241-5.

  19. Klein R, Klein BE, Knudtson MD, Wong TY, Cotch MF, Liu K, et al. Prevalence of age-related macular degeneration in 4 racial/ethnic groups in the multi-ethnic study of atherosclerosis. Ophthalmology 2006; 113: 373-80.

  20. Jampol LM, Tielsch J. Race, Macular degeneration, and the Macular Photocoagulation Study. Arch Ophthalmol 1992; 110: 1699-700.

  21. Seddon JM, Santangelo SL, Book K, Chong S, Cote JA. Genomewide scan for age-related macular degeneration provides evidence for linkage to several chromosomal regions. Am J Hum Genet 2003; 73: 780-90.

  22. Conley YP, Thalamuthu A, Jakobsdottir J, Weeks DE, Mah T, Ferrell RE, Gorin MB. Candidate gene analysis suggests a role for fatty acid biosynthesis and regulation of the complement system in the etiology of age-related maculopathy. Hum Mol Genet 2005; 14: 1991-2002.

  23. Donoso LA, Kim D, Frost A, Callahan A, Hageman G. The role of inflammation in the pathogenesis of age-related macular degeneration. Surv Ophthalmol 2006; 51: 137-52.

  24. Thakkinstian A, Han P, Mc Evoy M, Smith W, Hoh J, Magnusson K, et al. Systematic review and meta-analysis of the association between complement factor H Y402H polymorphisms and age-related macular degeneration. Hum Mol Genet 2006; 15: 2784-90.

  25. Jakobsdottir J, Conley YP, Weeks DE, Mah TS, Ferrell RE, Gorin MB. Susceptibility genes for age-related maculopathy on chromosome 10q26. Am J Hum Genet 2005; 77: 389-407.

  26. Leveziel N, Souied EH, Richard F, Barbu V, Zourdani A, Morineau G, et al. PLEKHA1-LOC387715-HTRA1 polymorphisms and exudative age-related macular degeneration in the French population. Mol Vis 2007; 13: 2153-9.

  27. Dowler S, Currie RA, Campbell DG, Deak M, Kular G, Downes CP, Alessi DR. Identification of pleckstrin-homology-domain- containing proteins with novel phosphoinositide-binding specificities. Biochem J 2000; 351: 19-31.

  28. Schmidt S, Hauser MA, Scott WK, Postel EA, Agarwal A, Gallins P, et al. Cigarette smoking strongly modifies the association of LOC387715 and age-related macular degeneration. Am J Hum Genet 2006; 78: 852-64.

  29. Khan JC, Thurlby DA, Shahid H, Clayton DG, Yates JR, Bradley M, et al. Genetic Factors in AMD Study. Smoking and age related macular degeneration: the number of pack years of cigarette smoking is a major determinant of risk for both geographic atrophy and choroidal neovascularization. Br J Ophthalmol 2006; 90: 75-80.

  30. Klein R, Knudtson MD, Cruickshanks KJ, Klein BE. Further observations on the association between smoking and the longterm incidence and progression of age-related macular degeneration: the Beaver Dam Eye Study. Arch Ophthalmol 2008; 126: 115-21.

  31. Hennekens CH, Buring JE, Manson JE, Stampfer M, Rosner B, Cook NR, et al. Lack of effect of long-term supplementation with betacarotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 1996; 334: 1145-9.

  32. Seddon JM, Christen WG, Manson JE, Buring JE, Sperduto RD, Hennekens CH. Low-dose aspirin and risks of cataract in a randomized trial of US physicians. Arch Ophthalmol 1991; 109: 252-5.

  33. Schaumberg DA, Christen WG, Hankinson SE, Glynn RJ. Body mass index and the incidence of visually significant agerelated maculopathy in men. Arch Ophthalmol 2001; 119: 1259-65.

  34. Seddon JM, Cote J, Davis N, Rosner B. Progression of age-related macular degeneration: association with body mass index, waist circumference, and waist-hip ratio. Arch Ophthalmol 2003; 121: 785-92.

  35. Anderson DH, Mullins RF, Hageman GS, Johnson LV. A role for local inflammation in the formation of drusen in the aging eye. Am J Ophthalmol 2002; 134: 411-31.

  36. Klein R, Klein BE, Tomany SC, Cruickshanks KJ. Of emphysema, gout, and inflammatory markers with long-term incidence of age-related maculopathy. Arch Ophthalmol 2003; 121: 674-8.

  37. Shankar A, Mitchell P, Rochtchina E, Tan J, Wang JJ. Association between circulating white blood cell count and long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study. Am J Epidemiol 2007; 165: 375-82.

  38. Seddon JM, Gensler G, Klein ML, Milton RC. C-reactive protein and homocysteine are associated with dietary and behavioral risk factors for age-related macular degeneration. Nutrition 2006; 22: 441-3.

  39. Seddon JM, Gensler G, Milton RC, Klein ML, Rifai N. Association between C-reactive protein and age-related macular degeneration. JAMA 2004; 291: 704-10.

  40. Tuo J, Smith BC, Bojanowski CM, Meleth AD, Gery I, Csaky KG, et al. The involvement of sequence variation and expression of CX3CR1 in the pathogenesis of age-related macular degeneration. FASEB J 2004; 18: 1297-9.

  41. Ding X, Patel M, Chan CC. Molecular pathology of age-related macular degeneration. Prog Retin Eye Res 2009; 28: 1-18.

  42. SanGiovanni JP, Chew EY, Clemons TE, Davis MD, Ferris FL 3rd, Gensler GR, et al.; Age-Related Eye Disease Study Research Group. The relationship of dietary lipid intake and age-related macular degeneration in a case-control study: AREDS Report No. 20. Arch Ophthalmol 2007; 125: 671-9.

  43. San Giovanni JP, Chew EY, Agrón E, Clemons TE, Ferris FL 3rd, Gensler G, et al.; Age-Related Eye Disease Study Research Group. The relationship of dietary omega-3 long-chain polyunsaturated fatty acid intake with incident age-related macular degeneration: AREDS report no. 23. Arch Ophthalmol 2008; 126: 1274-9.

  44. Chong EW, Robman LD, Simpson JA, Hodge AM, Aung KZ, Dolphin TK, et al. Fat consumption and its association with age-related macular degeneration. Arch Ophthalmol 2009; 127: 674-80.

  45. Chong EW, Kreis AJ, Wong TY, Simpson JA, Guymer RH. Dietary omega-3 fatty acid and fish intake in the primary prevention of age-related macular degeneration: a systematic review and meta-analysis. Arch Ophthalmol 2008; 126: 826-33.

  46. Pérez-Bautista O, Escobar-Arriaga E, Ramírez-Venegas, Sansores RH. Differences in inflammatory markers in a non-smoking and smoking Mexican population. Rev Invest Clin 2009; 61: 205-11.

  47. Lois N, Abdelkader E, Reglitz K. Enviromental tobacco smoke exposure and eye disease. Br J Ophthalmol 2008; 92: 1304-10.

  48. Shah SP, Dineen B, Jadoon Z, Bourne R, Khan MA, Johnson GJ, et al. Lens opacities in adults in Pakistan: prevalence and risk factors. Ophthalmic Epidemiol 2007; 14: 381-9.

  49. Nemet AY, Vinker S, Levartovsky S, Kaiserman I. Is cataract associated with cardiovascular morbidity. Eye 2010; 24: 1352-8.

  50. Lindblad BE, Håkansson N, Svensson H, Philipson B, Wolk A. Intensity of smoking and smoking cessation in relation to risk of cataract extraction: a prospective study of women. Am J Epidemiol 2005; 162: 73-9.

  51. Tan JS, Wang JJ, Younan C, Cumming RG, Rochtchina E, Mitchell P. Smoking and the long-term incidence of cataract: the Blue Mountains Eye Study. Ophthalmic Epidemiol 2008; 15: 155-6.

  52. Krishnaiah S, Vilas K, Shamanna BR, Rao GN, Thomas R, Balasubramanian D. Smoking and its association with cataract: results of the Andhra Pradesh eye disease study from India. Invest Ophthalmol Vis Sci 2005; 46: 58-65.

  53. Athanasiov PA, Edussuriya K, Senaratne T, Sennanayake S, Sullivan T, Selva D, Casson RJ. Cataract in central Sri Lanka: prevalence and risk factors from the Kandy Eye Study. Ophthalmic Epidemiol 2010; 17: 34-40.

  54. Athanasiov PA, Casson RJ, Sullivan T, Newland HS, Shein WK, Muecke JS, et al. Cataract in rural Myanmar: prevalence and risk factors from the Meiktila Eye Study. Br J Ophthalmol 2008; S92: 1169-74.

  55. Kelly SP, Thornton J, Edwards R, Sahu A, Harrison R. Smoking and cataract: review of causal association. J Cataract Refract Surg 2005; 31: 2395-404.

  56. Robman L, Taylor H. External Factors in the development of cataract. Eye 2005; 19: 1074-82.

  57. Kalariya NM, Nair B, Kalariya DK, Wills NK, van Kuijk FJ. Cadmium-induced induction of cell death in human lens epithelial cells: Implications to smoking associated Cataractogenesis. Toxicol Lett 2010; 198: 56-62.

  58. Mosad SM, Ghanem AA, El-Fallal HM, El-Kannishy AM, El Baiomy AA, Al-Diasty AM, Arafa LF. Lens cadmium, lead, and serum vitamins C, E, and beta carotene in cataractous smoking patients. Curr Eye Res 2010; 35: 23-30.

  59. Raju P, George R, Ve Ramesh S, Arvind H, Baskaran M, Vijaya L. Influence of tobacco use on cataract development. Br J Ophthalmol 2006; 90: 1374-7.

  60. Zanon-Moreno V, Garcia-Medina JJ, Zanon-Viguer V, Moreno- Nadal MA, Pinazo Duran MD. Smoking, an additional risk factor in elder women with primary open-angle glaucoma. Molecular Vision 2009; 15: 2953-59.

  61. Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 2006; 90: 262-7.

  62. Fechtner RD, Khouri AS. Evolving global risk assessment of ocular hypertension to glaucoma. Curr Opin Ophthalmol 2007; 18: 104-9.

  63. Cheng ACK, Pang CP, Leung ATS, Chua JKH, Fan DSP, Lam DSC The association between cigarette smoking and ocular diseases. HKMJ 2000; 6: 195-202.

  64. Bonovasa S, Filioussia K, Tsantesa A, Peponisb V. Epidemiological association between cigarette smoking and primary open-angle glaucoma: a meta-analysis. Public Health 2004; 118: 256-61.

  65. Edwars R, Thornton J, Ajit R, Harrison R, Kelly SP. Cigarette smoking and primary open angle glaucoma: A systematic review. J Glaucoma 2008; 17: 558-66.

  66. Fan BJ, Leung YF, Wang N, et al. Genetic and environmental risk factors for primary open-angle glaucoma. Chung Hua I Hsweh Tsa Chih 2004; 117: 706-10.

  67. Juronen E, Tasa G, Veromann S, et al. Polymorphic glutathione S-transferase M1 is a risk factor of primary openangle glaucoma among Estonians. Exp Eye Res 2000; 71: 447-52.

  68. Kaimbo DKW, Buntinx F, Missotten L. Risk factors for openangle glaucoma: a case-control study. J Clin Epidemiol 2001; 54: 166-71.

  69. Nemesure B, Wu SY, Hennis A, Leske MC. Factors related to the 4-year risk of high intraocular pressure the Barbados Eye Studies for the Barbados Eye Studies Group. Arch Ophthalmol 2003; 121: 856-62.

  70. Kang JH, Pasquale LR, Rosner BA, Willett WC, Egan KM, Faberowski N, Hankinson SE. Prospective study of cigarette. Smoking and the risk of primary open-angle glaucoma. Arch Ophthalmol 2003; 121: 1762-8.

  71. Doshi V, Ying-Lai M, Azen SP, Varma R; Los Angeles Latino Eye Study Group. Sociodemographic, family history, and lifestyle risk factors for open-angle glaucoma and ocular hypertension. The Angeles Latino Eye Study. Ophthalmology 2008; 115: 639-47.

  72. Co T, Niger R. The effects of cigarette smoking on intraocular Pressure and arterial blood Pressure of normotensive Young Nigerian male adults. J Physiol Sci 2007; 22: 33-6.

  73. Garrison GD, Dugan SE. Varenicline: a first-line treatment option for smoking cessation. Clin Ther 2009; 31: 463-91.

  74. McNeil JJ, Piccenna L, Loannides-Demos LL. Smoking cessation-recent advances. Cardiovasc Drugs Ther 2010; 24: 359-67.

  75. Urdapilleta-Herrera EC, Sansores R, Ramírez-Venegas A, et al. Ansiedad y depresión en fumadores mexicanos y su relación con el grado de adicción. Sal Púb Méx 2010; 52(Supl. 2): S120-S128.

  76. Gilbert-Lucido M, García-Huerta M, et al. Estudio epidemiológico de glaucoma en población mexicana. Rev Mex Oftalmol 2010; 84(2): 86-90.

  77. Barojas-Weber E, San Juan-Estrada E, Ortega-Larrocea G. Reporte de una campaña quirúrgica de catarata del Instituto Nacional de Salud. Rev Mex Oftalmol 2010; 84(2): 91-5.




2020     |     www.medigraphic.com